Delayed Graft Function clinical trials at UCSF

1 in progress, 0 open to eligible people

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney
Sorry, in progress, not accepting new patients
The major objective is to demonstrate the safety and efficacy of ANG-3777 in improving graft function and reducing the severity of delayed graft function (DGF) in recipients at high risk of DGF after receiving a deceased donor renal allograft.
San Francisco, California and other locations

Last updated: June 2021